Molecular Autism, a new journal published by BioMed Central, is now accepting submissions.
Molecular Autism aims to be the major forum for research into the molecular basis of autism and related neurodevelopmental conditions. The journal will focus on research that relates causal and risk factors with these conditions, leading to model systems and novel therapeutics. This will include studies of genetics, neuropathology, neuroimaging, biomarkers, and molecular neurobiology.
The primary focus is on conditions in the autism spectrum (including Asperger syndrome), but the scope also encompasses molecular research into related neurodevelopmental conditions such as specific language impairment, dyspraxia, and specific or general developmental delays; and into related medical syndromes such as fragile X syndrome, tuberous sclerosis, and Rett syndrome.
Molecular Autism is edited by Professors Joseph D Buxbaum (Mount Sinai School of Medicine) and Simon Baron-Cohen (University of Cambridge) and supported by an expert international Editorial Board.
For more details on Molecular Autism, please see the journal’s information pages, or contact the editorial office. To keep up to date with new developments and to receive a copy of the print preview of our inaugural issue, simply register your email address on the website.
Submit your next piece of research to Molecular Autism now to ensure the high visibility of your work and benefit from no limits on word count or colour figures, rapid, high quality peer review and immediate publication on acceptance.
Assistant Journal Development Editor